Clinical Trial to Evaluate the Safety and Efficacy of Scarclinic™ Thin in Surgical Scars

Hypertrophic Surgical Scar Clinical Trial

Official title: Phase 4 Study of Scarclinic™ Thin That Treats Surgical Scars.

Status Completed

Clinical Trial Summary

Compare the efficacy and safety of Scarclinic™Thin and Scarclinic™ Normal for the treatment of surgical scars.

Participant: 40 Treatment period : 3 months Medical device: Scarclinic™Thin , Scarclinic™ Normal Randomization: Table of random number

Clinical Trial Description

For evaluating the efficacy

• The investigator check Vancouver Scar Scale at 1 and 3 month after application to evaluate vascularity, pigmentation, elasticity, height, pain and itchiness

• The participant filled out survey included questions regarding convenience in use at 1 and 3 month after application. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Hypertrophic Surgical Scar

• NCT number: NCT01689857
• Study type: Interventional
• Source: Seoul National University Hospital
• Status: Completed
• Phase: N/A
• Start date: October 2010
• Completion date: August 2012